StemCell Therapy

Just as every person is unique, so is every cancer. At the Knight Cancer Institute, were dedicated to finding what makes each cancer unique and providing individually tailored and targeted treatments.

Our pioneering work in personalized medicine ultimately led to the discovery of one of the worlds first targeted cancer drugs, Gleevec, by Dr. Brian Druker at the OHSU Knight Cancer Institute. Gleevec truly revolutionized the way cancer is treated and works by zeroing in and eliminating specific cancer-causing cells, while avoiding serious damage to other non-cancerous ones. This major turning point in the treatment of cancer has led us to expand our focus on delivering personalized care by recruiting the very best and most experienced clinicians and researchers from across the country. But we wont stop there! Through our efforts in cancer research, diagnostics, drug development and treatments, we continue to lead the way in the field of personalized care.

Dr. Druker has stated that Our goal going forward is to advance science so that someday there will be a targeted therapy to shut down every form of cancer. At the OHSU Knight Cancer Institute, each of us believes in a world without cancer and has a mission to end this disease in our lifetime.

Asleadersinthefieldofpersonalizedmedicine,weare investing in:

At the Knight Cancer Institute our physicians, pathologists, researchers and other member of the team work together to bring each patient the best personalized care available. For us it truly is:

See more here:
Personalized Cancer Medicine | Knight Cancer Institute | OHSU

This entry was posted on June 30, 2018 at 1:44 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |